Mackenzie Financial Corp Spero Therapeutics, Inc. Transaction History
Mackenzie Financial Corp
- $66.8 Billion
- Q3 2024
A detailed history of Mackenzie Financial Corp transactions in Spero Therapeutics, Inc. stock. As of the latest transaction made, Mackenzie Financial Corp holds 31,903 shares of SPRO stock, worth $40,516. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31,903
Previous 32,729
2.52%
Holding current value
$40,516
Previous $42,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding SPRO
# of Institutions
49Shares Held
13.9MCall Options Held
200Put Options Held
200-
Anson Funds Management LP Dallas, TX3.75MShares$4.76 Million0.6% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.76MShares$2.24 Million0.0% of portfolio
-
Atlas Venture Associates Ix, LLC Boston, MA1.35MShares$1.72 Million14.54% of portfolio
-
Acadian Asset Management LLC Boston, MA1.07MShares$1.36 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny975KShares$1.24 Million0.0% of portfolio
About Spero Therapeutics, Inc.
- Ticker SPRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,067,500
- Market Cap $44.5M
- Description
- Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...